Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the first quarter of 2024 of $1.19 per share on the...
Tome Biosciences, Inc., announces that it has acquired Replace Therapeutics Inc., a private biotechnology company developing a novel PGI method capable of inserting and deleting small...
Altamira Therapeutics Ltd. announced that it received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market on December 28, 2023,...
Pyxis Oncology, Inc. reported that Pyxis Oncology’s Compensation Committee of the Board of Directors approved a stock option grant to Ken Kobayashi, M.D., the Company’s newly...
Cano Health, Inc. announced that it was notified by NYSE Regulation Inc. that it is not in compliance with Section 802.01B of the NYSE Listed Company...
ImmunityBio, Inc. announced an up to $320 million royalty financing and equity investment in the Company by Oberland Capital, with $210 million of gross proceeds received...
Roche announced the entry into a definitive agreement to acquire select parts of the LumiraDx group related to LumiraDx’s innovative Point of Care technology. Following closing...
Apollo Therapeutics announces that during December 2023 it completed a second close of its Series C financing, raising an additional $33.5 million and bringing the total...
Aditxt, Inc., announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,237,114 shares of common stock (or pre-funded...
MedBright AI Investments Inc. announced that further to its press releases dated September 8, 2023 and October 17, 2023, Vinergy Acquisition Corp., a wholly owned US...
Microbot Medical Inc. announced the entry into a definitive agreement for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate...
Apple’s widening effort to turn its nine-year-old watch from a luxury timepiece into the ultimate all-in-one medical device is taking it into territory that is legally...
Bluejay Diagnostics, Inc. announced the pricing of a public offering of 2,692,308 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and warrants...
Probo Medical has signed a definitive purchase agreement to acquire Alpha Source Group in a deal that significantly expands Probo’s diagnostic imaging solutions platform. Alpha Source...
Inspira Technologies OXY BHN Ltd. announces the closing of its previously announced registered direct offering of 3,031,250 ordinary shares (or ordinary share equivalents in lieu thereof),...
Copyright © 2024 Medical Buyer